Total Payments
$6,829
2021 Payments
$60.00
Companies
23
Transactions
421
Medicare Patients
2,002
Medicare Billing
$261,760
Payment Breakdown by Category
Food & Beverage$6,621 (97.0%)
Education$208.14 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,621 | 398 | 97.0% |
| Education | $208.14 | 23 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,347 | 73 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $1,006 | 58 | $0 (2020) |
| GlaxoSmithKline, LLC. | $836.06 | 66 | $0 (2020) |
| Genentech USA, Inc. | $613.79 | 36 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $504.39 | 42 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $348.73 | 20 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $313.37 | 15 | $0 (2020) |
| Mallinckrodt Enterprises LLC | $222.34 | 12 | $0 (2019) |
| Grifols USA, LLC | $209.09 | 13 | $0 (2019) |
| GENZYME CORPORATION | $171.24 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $60.00 | 16 | United Therapeutics Corporation ($60.00) |
| 2020 | $445.74 | 27 | AstraZeneca Pharmaceuticals LP ($86.39) |
| 2019 | $3,045 | 161 | Boehringer Ingelheim Pharmaceuticals, Inc. ($503.15) |
| 2018 | $2,520 | 167 | Boehringer Ingelheim Pharmaceuticals, Inc. ($544.04) |
| 2017 | $758.43 | 50 | Boehringer Ingelheim Pharmaceuticals, Inc. ($223.19) |
All Payment Transactions
421 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2021 | United Therapeutics Corporation | ORENITRAM (Drug) | Education | In-kind items and services | $7.50 | General |
| Category: PAH | ||||||
| 10/01/2021 | United Therapeutics Corporation | ORENITRAM (Drug) | Education | In-kind items and services | $7.50 | General |
| Category: PAH | ||||||
| 10/01/2021 | United Therapeutics Corporation | ORENITRAM (Drug) | Education | In-kind items and services | $2.50 | General |
| Category: PAH | ||||||
| 10/01/2021 | United Therapeutics Corporation | TYVASO (Drug) | Education | In-kind items and services | $2.50 | General |
| Category: PAH | ||||||
| 10/01/2021 | United Therapeutics Corporation | ORENITRAM (Drug) | Education | In-kind items and services | $2.50 | General |
| Category: PAH | ||||||
| 10/01/2021 | United Therapeutics Corporation | — | Education | In-kind items and services | $2.50 | General |
| 10/01/2021 | United Therapeutics Corporation | — | Education | In-kind items and services | $2.50 | General |
| 06/30/2021 | United Therapeutics Corporation | ORENITRAM (Drug) | Education | In-kind items and services | $7.50 | General |
| Category: PAH | ||||||
| 06/30/2021 | United Therapeutics Corporation | ORENITRAM (Drug) | Education | In-kind items and services | $7.50 | General |
| Category: PAH | ||||||
| 06/30/2021 | United Therapeutics Corporation | ORENITRAM (Drug) | Education | In-kind items and services | $2.50 | General |
| Category: PAH | ||||||
| 06/30/2021 | United Therapeutics Corporation | ORENITRAM (Drug) | Education | In-kind items and services | $2.50 | General |
| Category: PAH | ||||||
| 05/25/2021 | United Therapeutics Corporation | ORENITRAM (Drug) | Education | In-kind items and services | $2.50 | General |
| Category: PAH | ||||||
| 05/25/2021 | United Therapeutics Corporation | ORENITRAM (Drug) | Education | In-kind items and services | $2.50 | General |
| Category: PAH | ||||||
| 05/25/2021 | United Therapeutics Corporation | ORENITRAM (Drug) | Education | In-kind items and services | $2.50 | General |
| Category: PAH | ||||||
| 05/25/2021 | United Therapeutics Corporation | ORENITRAM (Drug) | Education | In-kind items and services | $2.50 | General |
| Category: PAH | ||||||
| 05/25/2021 | United Therapeutics Corporation | TYVASO (Drug) | Education | In-kind items and services | $2.50 | General |
| Category: PAH | ||||||
| 06/10/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.61 | General |
| 03/12/2020 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: RESPIRATORY | ||||||
| 03/11/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: RESPIRATORY | ||||||
| 03/10/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: RESPIRATORY | ||||||
| 03/09/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/06/2020 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Respiratory and Allergy | ||||||
| 03/06/2020 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $12.10 | General |
| Category: Dental and Oral Health | ||||||
| 03/05/2020 | Sunovion Pharmaceuticals Inc. | UTIBRON NEOHALER (Drug), SEEBRI NEOHALER, LONHALA MAGNAIR | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Respiratory | ||||||
| 03/03/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 353 | 469 | $211,057 | $54,968 |
| 2022 | 8 | 323 | 422 | $156,077 | $45,774 |
| 2021 | 8 | 450 | 616 | $244,087 | $68,777 |
| 2020 | 13 | 876 | 1,055 | $324,698 | $92,242 |
Total Patients
2,002
Total Services
2,562
Medicare Billing
$261,760
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 44 | 111 | $95,793 | $17,504 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 143 | 173 | $44,115 | $14,255 | 32.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 57 | 75 | $25,800 | $9,295 | 36.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 52 | 52 | $25,480 | $8,391 | 32.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $11,310 | $3,304 | 29.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 14 | $6,804 | $1,790 | 26.3% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 15 | 15 | $1,755 | $428.70 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 176 | 240 | $61,200 | $21,109 | 34.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 28 | 55 | $47,465 | $9,518 | 20.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $17,940 | $5,466 | 30.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 20 | 20 | $9,800 | $2,857 | 29.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 16 | $7,776 | $2,702 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 16 | $5,504 | $2,085 | 37.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 18 | $4,500 | $1,478 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $1,892 | $558.68 | 29.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 222 | 323 | $82,365 | $29,250 | 35.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 58 | 113 | $97,041 | $19,926 | 20.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 64 | 64 | $31,452 | $9,807 | 31.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 35 | 35 | $12,040 | $4,626 | 38.4% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 12 | 22 | $8,470 | $2,070 | 24.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $7,020 | $1,789 | 25.5% |
| 94375 | Respiratory diagnostic testing (flow volume loop) | Office | 2021 | 30 | 30 | $3,510 | $843.66 | 24.0% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 11 | 11 | $2,189 | $464.82 | 21.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 76 | 149 | $115,151 | $26,348 | 22.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 199 | 269 | $68,595 | $20,564 | 30.0% |
About Dr. Rex Sagalla, DO
Dr. Rex Sagalla, DO is a Internal Medicine healthcare provider based in Stony Brook, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1174784516.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rex Sagalla, DO has received a total of $6,829 in payments from pharmaceutical and medical device companies, with $60.00 received in 2021. These payments were reported across 421 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($6,621).
As a Medicare-enrolled provider, Sagalla has provided services to 2,002 Medicare beneficiaries, totaling 2,562 services with total Medicare billing of $261,760. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Stony Brook, NY
- Active Since 06/18/2008
- Last Updated 06/01/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1174784516
Products in Payments
- OFEV (Drug) $690.81
- FASENRA (Drug) $571.17
- STIOLTO RESPIMAT (Drug) $533.37
- Xolair (Biological) $444.20
- NUCALA (Biological) $430.48
- SYMBICORT (Drug) $371.92
- XOLAIR (Biological) $348.73
- DUPIXENT (Biological) $293.77
- LONHALA MAGNAIR (Drug) $269.81
- ACTHAR (Biological) $222.34
- Utibron (Drug) $173.48
- Prolastin-C Liquid (Biological) $171.65
- Esbriet (Biological) $150.52
- TRELEGY ELLIPTA (Drug) $147.62
- DUPIXENT (Drug) $146.74
- Arikayce (Drug) $136.78
- Pulmonx Endobronchial Valve EBV (Device) $116.18
- ZERBAXA (Drug) $112.20
- BREO (Drug) $108.87
- The Vest System Model 105 Home Care (Device) $107.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Stony Brook
Dr. Ewa Rakowski, Md, MD
Internal Medicine — Payments: $9,413
Internal Medicine $9,413
Dr. Anna Ahn, M.d, M.D
Internal Medicine — Payments: $6,141
Internal Medicine $6,141
Dr. Daniel Montellese, Md, MD
Internal Medicine — Payments: $5,201
Internal Medicine $5,201
Dr. Kanhai Farrakhan, Md, MD
Internal Medicine — Payments: $4,349
Internal Medicine $4,349
Dr. Travis Bench, Md, MD
Internal Medicine — Payments: $4,212
Internal Medicine $4,212
Negin Yaghooti, M.d, M.D
Internal Medicine — Payments: $4,149
Internal Medicine $4,149